Search research articles
Contact Us
Filters
Showing results (1251-1260 of 1,303) with videos related to
Page
of 131
Sort By:
Mass Spectrometry Reviews
|
February 2, 2019
Recommendations for reporting ion mobility Mass Spectrometry measurements
Valérie Gabelica, Alexandre A Shvartsburg, Carlos Afonso, et al.
Blood Advances
|
March 14, 2025
Evidence-based risk stratification of myeloid neoplasms harboring TP53 mutations
Mithun Vinod Shah, Kevin Hung, Anmol Baranwal, et al.
American Journal of Human Genetics
|
December 1, 2014
Mutations in RAB39B cause X-linked intellectual disability and early-onset Parkinson disease with α-synuclein pathology
Gabrielle R Wilson, Joe C H Sim, Catriona McLean, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
December 31, 2021
A Core Outcome Set for Trials in Glomerular Disease: A Report of the Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD) Stakeholder Workshops
Simon A Carter, Liz Lightstone, Dan Cattran, et al.
Kidney International
|
May 8, 2021
Development of an international Delphi survey to establish core outcome domains for trials in adults with glomerular disease
Simon A Carter, Charlotte Logeman, Martin Howell, et al.
Blood Advances
|
August 15, 2025
The MAGIC Composite Response: A Novel Endpoint Integrating Clinical and Biomarker Parameters for Acute GVHD
Yu Akahoshi, Joseph Portelli, Nikolaos Katsivelos, et al.
Transplantation and Cellular Therapy
|
February 6, 2024
A Day 14 Endpoint for Acute GVHD Clinical Trials
Nikolaos Spyrou, Yu Akahoshi, Steven Kowalyk, et al.
Blood Cancer Journal
|
May 7, 2025
Validation of the 5th edition of the World Health Organization and International Consensus Classification guidelines for TP53-mutated myeloid neoplasm in an independent international cohort
Mithun Vinod Shah, Kevin Hung, Anmol Baranwal, et al.
Bone Marrow Transplantation
|
July 11, 2018
Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement
Wilson I Gonsalves, Francis K Buadi, Sikander Ailawadhi, et al.
Blood Advances
|
December 10, 2019
The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease
Hrishikesh K Srinagesh, Umut Özbek, Urvi Kapoor, et al.
Page
of 131
Search research articles
Search
Showing results (1251-1260 of 1,303) with videos related to
Sort By:
Page
of 131
Mass Spectrometry Reviews
|
February 2, 2019
Recommendations for reporting ion mobility Mass Spectrometry measurements
Valérie Gabelica, Alexandre A Shvartsburg, Carlos Afonso, et al.
Blood Advances
|
March 14, 2025
Evidence-based risk stratification of myeloid neoplasms harboring TP53 mutations
Mithun Vinod Shah, Kevin Hung, Anmol Baranwal, et al.
American Journal of Human Genetics
|
December 1, 2014
Mutations in RAB39B cause X-linked intellectual disability and early-onset Parkinson disease with α-synuclein pathology
Gabrielle R Wilson, Joe C H Sim, Catriona McLean, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
December 31, 2021
A Core Outcome Set for Trials in Glomerular Disease: A Report of the Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD) Stakeholder Workshops
Simon A Carter, Liz Lightstone, Dan Cattran, et al.
Kidney International
|
May 8, 2021
Development of an international Delphi survey to establish core outcome domains for trials in adults with glomerular disease
Simon A Carter, Charlotte Logeman, Martin Howell, et al.
Blood Advances
|
August 15, 2025
The MAGIC Composite Response: A Novel Endpoint Integrating Clinical and Biomarker Parameters for Acute GVHD
Yu Akahoshi, Joseph Portelli, Nikolaos Katsivelos, et al.
Transplantation and Cellular Therapy
|
February 6, 2024
A Day 14 Endpoint for Acute GVHD Clinical Trials
Nikolaos Spyrou, Yu Akahoshi, Steven Kowalyk, et al.
Blood Cancer Journal
|
May 7, 2025
Validation of the 5th edition of the World Health Organization and International Consensus Classification guidelines for TP53-mutated myeloid neoplasm in an independent international cohort
Mithun Vinod Shah, Kevin Hung, Anmol Baranwal, et al.
Bone Marrow Transplantation
|
July 11, 2018
Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement
Wilson I Gonsalves, Francis K Buadi, Sikander Ailawadhi, et al.
Blood Advances
|
December 10, 2019
The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease
Hrishikesh K Srinagesh, Umut Özbek, Urvi Kapoor, et al.
Page
of 131